Information Provided By: 
Fly News Breaks for March 27, 2017
PKI
Mar 27, 2017 | 09:12 EDT
As previously reported, Janney Capital analyst Paul Knight upgraded PerkinElmer to Buy from Neutral, saying he sees the pending sale of its Medical Imaging business and its realignment to highlight the value of its Diagnostic and DAS platforms and drive a re-rating of shares. The analyst, who sees asset sales, spin-off and acquisition potential, and margin expansion among the levers available to PerkinElmer, raised his fair value estimate on the shares to $75 from $55.
News For PKI From the Last 2 Days
There are no results for your query PKI
